Anti-Biofilm replaced Prevent.Pro – available from May, 2018
(introductory price reduction is in effect)
Anti-Biofilm was specifically developed to disrupt chronic biofilm communities, containing bacteria, viruses, fungus, and parasites.
At least two million people get infected and at least 23,000 die yearly in the US due to bacteria that is resistant to antibiotics.
Anti-Biofilm is the first and only natural product supercharged with EDTA, besides containing a powerful combination of broad-spectrum herbs, that was specifically formulated against resistant bacteria and other infectious agents (viruses, fungus and parasites).
Over 90% of chronic infections are biofilm related and have a key role on treatment and antimicrobial resistance, yet, biofilms are under-diagnosed and generally ignored. More importantly, the results of medical studies are ignored as mainstream medicine rather let patients die than incorporate into the treatment modalities antibiotic boosting compounds, such as EDTA. Every hospital has IV EDTA units for chronic lead (Pb) toxic overload. Yet, nobody in a hospital brings some EDTA to the Infectious Unit to supercharge the antibiotic’s effects against resistance bacteria and save the patients. Not lack of knowledge or ability but rather pure ignorance and a kind of ‘tunnel vision’ results in the killing of 23,000 patients from resistant bacteria.
The anti-bacterial herbs are always superior to antibiotics
Bacteria can develop resistance against one drug, containing a synthetic compound that is typically targets one receptor site or one biochemical step. There is no chance for a bacteria to develop resistance against 40 biologically active alkaloids found in a herb. A combination of herbs, found in Anti-Biofilm is an absolute guarantee against the development of any bacterial resistance ever. This is why anti-bacterial herbs are always superior to antibiotics. Also, herbs or rather herbal combinations, such as found in Anti-Biofilm, are not too specific and too selective to target only bacteria but also targets fungus (Candida) and viruses. This broad approach ensures that Candida can’t get out of control. When only antibiotics are taken, often fungal infections become a concern.
Finally, herbs have immune boosting aspects that is highly desirable in all chronic conditions.
It is not widely known, but Ca-EDTA can break bacterial resistance [1,2].
Three percent of methicillin-susceptible S. aureus and 11% of methicillin-resistant S. aureus were found to be gentamicin resistant in a recent survey of hospital-acquired infections in Texas .
In Canadian ICUs, 8% of E. coli and 32% of P. aeruginosa were gentamicin resistant .
More strikingly, 60% of S. epidermidis responsible for BSI in Germany were gentamicin resistant .
Thus, identifying the most active approach against gentamicin-resistant bacteria is essential.
Catheter-related bloodstream infections (CRBSI) are often hampered by the characteristic tolerance of bacterial biofilms towards antibiotics. In a French study, published in 2015, it was yet again confirmed that EDTA significantly increased the effect of antibiotics against biofilms formed by Gram-positive and Gram-negative bacterial pathogens. The study had wide-ranging conclusions about the highly beneficial effects of EDTA. Gentamicin was associated with higher killing of biofilm bacteria compared with vancomycin against all tested strains apart from one S. aureus. Conversely, against S. epidermidis, vancomycin was more active than gentamicin against two strains, less active against one strain and equally active against one strain. Against Gram-positive bacteria, the addition of EDTA increased the killing of biofilm bacteria in all cases .
Yet another study confirmed the effects of a herb, yellow alder, potentiated the antibiotic activity against methicillin—resistant Staphylococcus aureus (MRSA). It’s expected that once studied, a very long list of other ‘herbal antibiotics’, also found in Anti-Biofilm, would have a somewhat similar antibiotic boosting effect.
The conclusion is that both EDTA and herbs can potentiate the increasingly failing antibiotics. Yet, doctors are not changing their standard protocols and they don’t add EDTA and/or herbs to the treatment regimen of those patients when the selected antibiotic fails to eliminate the bacteria. This neglect results in the death of 23,000 patients in the US. There is no scientific, ‘ethical’ or medical logic in the refusal of saving lives.
Anti-Biofilm has broader effects than just supercharging antibiotics
While current parasitic control relies heavily on anthelmintic drugs, to which resistance is growing rapidly, proteolytic enzymes can be used against parasites [8, 9, 10] with greater success than anti-parasitic drugs.
We live in a toxic world that compromises our immune system, even though we’re exposed to microbes, some natural and others are man-made or man-distributed (chemtrails and live viruses in vaccinations).
The ‘One World, One Health’ initiative is an emerging approach to deal with interrelated human, animal, and environmental health imbalances where emerging diseases are infectious in nature (zoonosis). The powerful Anti-Biofilm supports the body to remain healthy in this challenging environment. Anti-Biofilm’s ingredients were carefully selected for synergistic action when the protection of our body against pathogens is a priority.
180 vegetable capsules per bottle (double the number of capsules, compared to Prevent.Pro)
Take two times three capsules per day.
35 ingredients – per 3 vegetable capsules
- Cat’s Claw Bark, 3% — 100mg
- Milk Thistle Seed, PE, 80% /Silymarin — 75mg
- Ashwagandha Root, Organic — 100mg
- Red Grape Seed, 95% — 50mg
- Turmeric, 95% Curcuminoids — 100mg
- Black pepper, bioperine PE, 95% piperine, 50:1 — 2mg
- Green Tea Extr. 95%, Poly 50% EGCG, 20:1 — 50mg
- Asian Ginseng root, — 50mg
- Reishi Ganoderma Lucidum, Organic — 100mg
- Fucoxanthin — 1mg
- Ginkgo biloba PE, 24% FG, 6% TL — 25mg
- Maca root PE 5:1 — 50mg
- Hawthorn Berries (Crataegus oxyacantha) — 75mg
- European Elder fruit — 100mg
- Black Walnut hulls, Organic — 200mg
- Cinnamon Cassia bark — 125mg
- Serrapeptase, 600 000 U/gm — 166,666 Unit
- Black Cumin — 125mg
- Papain, 48,000 PU/gm 2,— 160 mg
- Quercetin — 100mg
- Berberine — 100mg
- Humic-Acid/Fumic Acid — 38mg
- Bacillus coagulant (Prebiotic) — 40mg
- 8 Strain Probiotic Blend 100 billion CFU/g — 25mg
- Oregano Leaf Organic — 200mg
- EDTA amino acid — 250mg
- Garlic Organic — 200mg
- Selenium — 150 mcg
 Farca AM, Piromalli G, Maffei F, Re G. Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis. J Small Anim Pract 1997; 38: 243-245.
 Bezalwar et al. Potentiating Effect of EDTA on Antibiotics Resistant Staphylococcus aureus. IOSR Journal of Nursing and Health Science, Volume 3, Issue 2 Ver. IV (Mar-Apr. 2014), PP 45-47
 Hulten KG Kaplan SL Lamberth LB et al. Hospital-acquired Staphylococcus aureus infections at Texas Children’s Hospital, 2001–2007. Infect Control Hosp Epidemiol 2010; 31:183–90.
 Zhanel GG DeCorby M Laing Net al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 2008;52:1430–7.
 von Eiff C Reinert RR Kresken Met al. Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin. J Clin Microbiol 2000; 38: 2819–23.
 Chauhan A., et al., Full and broad-spectrum in vivo eradication of catheter-associated biofilms using gentamicin-EDTA antibiotic lock therapy. Antimicrob. Agents Chemother. December 2012 vol. 56 no. 12 6310-6318.
 Henrique DE Coutinho, et. al.; Herbal therapy associated with antibiotic therapy: potentiation of the antibiotic activity against methicillin – resistant Stephylococcus aureus by Turnera ulmifolia L,; BMC Complement Altern Med. 2009; 9: 13.
 G. Stepek et.al., Natural plant cysteine proteinases as anthelmintics? Trends in Parasitology, Vol. 20, Issues 7, July 2004, Pages 322–327
 G. Stepek et. al. Assessment of the anthelmintic effect of natural plant cysteine proteinases against the gastrointestinal nematode, Heligmosomoides polygyrus, in vitro Parasitology, VOl. 130, Issue 2, February 2005, 203-211
 G. Stepek et. al. In vitro and in vivo anthelmintic efficacy of plant cysteine proteinases against the rodent gastrointestinal nematode, Trichuris muris Parasitology, Vol. 132, Issue 5, May 2006, pp. 681-689